Nu Skin Enterprises, Inc.
NUS
$8.48
-$0.09-1.05%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 140.14% | 105.72% | 117.86% | 20,271.67% | -595.81% |
| Total Depreciation and Amortization | -21.50% | -30.19% | -25.85% | -22.95% | -11.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -49.72% | 56.08% | -94.16% | -687.95% | 297.12% |
| Change in Net Operating Assets | -375.22% | -462.27% | -87.24% | 41.25% | -46.91% |
| Cash from Operations | -35.54% | -12.57% | -30.10% | -88.28% | -52.40% |
| Capital Expenditure | 14.49% | -15.34% | 99.78% | -10.61% | 38.27% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 196.25% | -100.00% | 2,259.56% | -53.53% | -120.83% |
| Cash from Investing | 28.35% | -51.44% | 203.07% | 2,060.10% | 11.53% |
| Total Debt Issued | -- | 166.67% | -- | -- | -- |
| Total Debt Repaid | 86.49% | -48.83% | 78.67% | -648.72% | -4,873.53% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -18,138.98% | -9,403.77% | -- | -226.49% | 67.22% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 2.58% | 0.70% | 0.60% | -0.77% | 84.52% |
| Other Financing Activities | -- | -- | -- | 76.22% | -- |
| Cash from Financing | 57.59% | 6.61% | 132.16% | -420.40% | -115.28% |
| Foreign Exchange rate Adjustments | 83.87% | -141.41% | 405.14% | 122.20% | -321.87% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 67.81% | -453.38% | 415.35% | 138.80% | -279.69% |